Wide Range of resources on complex issues
We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.
The Sentinel System— An Overview of FDA’s Tools for Assessing Medical Product Safety and Gathering Real-World Evidence
08/21/2019The Sentinel System— An Overview of FDA’s Tools for Assessing Medical Product Safety and Gathering Real-World Evidence This webinar provided an overview of Sentinel’s growing
Member Spotlight: Caregiver Action Network
08/19/2019By Katherine Scott, Senior Manager, Membership Services and Certifications Caregiver Action Network (CAN) is the nation’s leading family caregiver organization working to improve the quality of
NHC CEO Marc Boutin on Patients as Partners in Innovation, Education, and More at eyeforpharma
08/15/2019By Christina Howerton, Manager, Communications and New Media In April, National Health Council Chief Executive Marc Boutin, JD, participated in a fireside chat with Percival
Centers for Medicare & Medicaid Services’ (CMS’) Request for Information: Reducing Administrative Burden to Put Patients over Paperwork
08/13/2019The National Health Council (NHC) appreciates the opportunity to respond to the Centers for Medicare & Medicaid Services’ (CMS’) Request for Information entitled “Reducing Administrative
Registration Now Open: 2019 Science of Patient Engagement Symposium
08/12/2019By Silke Schoch, Senior Associate, Programs The National Health Council (NHC) is excited to welcome research leaders, and anyone interested in the science of patient
NHC Comment Letter: Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs—Guidance for Industry
08/08/2019By Maddie Mason, Associate, Policy The U.S. Food and Drug Administration (FDA) released draft guidance for industry titled “Enhancing the Diversity of Clinical Trial Populations
Food and Drug Administration’s (FDA’s) Draft Guidance on Enhancing the Diversity of Clinical Trial Populations
08/06/2019The National Health Council (NHC) appreciates the opportunity to provide comments on the Food and Drug Administration’s (FDA’s) draft guidance on Enhancing the Diversity of
Core Outcome Sets – What are They?
08/05/2019By Aimee Lee Russell, Associate, Programs On Monday, July 15, Donna Messner, PhD, CEO and President of the Center for Medical Technology Policy (CMTP) introduced core
NHC 2019 Science of Patient Engagement Symposium Highlights Using Data Science, Technology, and Patient Engagement to Personalize Health Care
08/01/2019By Silke Schoch, Senior Associate, Programs On October 28 and 29, the National Health Council (NHC) held its third annual Science of Patient Engagement Symposium